Oracle Health Sciences study explores status of precision medicine initiatives and challenges
March 7, 2018
Oracle Health Sciences today announced the results of a new study that explores the current and planned status of precision medicine initiatives, associated challenges and the future impact of this discipline on life sciences and healthcare communities.
Conducted by GenomeWeb and sponsored by Oracle Health Sciences, the study revealed perspectives on the state of precision medicine from 316 scientists, researchers and other members of the life sciences and healthcare industries. While these communities have largely embraced the concept behind precision medicine — using the molecular makeup of patients in order to improve the diagnosis and treatment of disease — the survey captured a deeper look into the current and future statuses, approaches and implementations of precision medicine initiatives.
https://www.news-medical.net/news/20180307/Oracle-Health-Sciences-study-explores-status-of-precision-medicine-initiatives-and-challenges.aspx
